Sílvia Casacuberta Serra

Sílvia Casacuberta Serra has extensive experience in the field of oncology research. Sílvia began their career in 2009 as a research fellow at the Institut de Recerca Hopital Universitari de la Vall d'Hebron. In 2010, they completed their Master's Thesis before moving on to a pre-doctoral position at the Vall d'Hebron Institute of Research (VHIR) in 2011. During this time, their work focused on inducing immunological tolerance using antigen-specific myeloid-derived suppressor cells (MDSCs) and generating MDSCs for potential clinical applications. Sílvia continued their research at the same institution as a postdoctoral research scientist from 2016 to 2019. Additionally, they held a postdoctoral research scientist role at the Vall d´Hebron Institute of Oncology (VHIO) during the same period. Since 2019, Sílvia has been serving as the Immuno-Oncology Project Manager at Peptomyc.

Sílvia Casacuberta Serra's education history is as follows:

In 2022, they attended La Salle BCN and pursued a degree in Leadership and Management Capacities.

In 2021, they also studied at La Salle BCN, where they took a course in Project Management in Pharma and Biotechs.

In 2020, Sílvia completed an online course in Good Laboratory Practices (GLP) at IAVANTE.

From 2019 to 2020, they attended La Salle BCN and obtained a University Expert degree in Project Management with a specialization in Project Management.

In 2011, they enrolled at the Universitat Autònoma de Barcelona and earned a Ph.D. in Immunology.

In 2010, Sílvia pursued a Biomedicine Master's degree at the Universitat de Barcelona.

From 2006 to 2010, they studied at the Universitat de Vic – Universitat Central de Catalunya and graduated with a degree in Biotechnology.

Sílvia also completed an additional online course in Good Laboratory Practices (GLP) at IAVANTE, although the specific dates for this course are not provided.